Share This

Hot News

B股沛嘉首日孖展熱爆超購225倍引14基投鎖定一半集資額- 20200506 - 經濟 @ 2020-05-07T16: Back Hot News
Keyword:孖展 沛嘉醫療 超購 首日 新股
Concept:沛嘉醫療首日招股超購
【明報專訊】未盈利生科股浪潮愈炒愈高,昨日起招股的醫械股沛嘉醫療(9996)首日錄券商借出孖展530億元,成今年首日吸金最多的新股,更有望挑戰康方 ...
繼康方生物(9926)後,本港短期內再迎來另一只「B股」。沛嘉醫療(9996)周二首日招股,次日孖展額已突破600億元,超額認購277倍,有望超越康方生.
沛嘉醫療(9996)今日第二日招股,招股反應持續強勁,綜合五間證券行累計共借出664.1億元孖展,較昨日增加逾百億元,以公開發售集資額2.34億元計,超購約283倍 ...
尚未有盈利或收入生物科技股熱潮停不了!沛嘉醫療(09996)周三踏入第二日招股期,孖展進一步超購。綜合12家券商,累計為.
無收入生物科技上市公司(B股)熱潮停不了!沛嘉醫療(09996)昨天首日招股已獲投資者重錘出擊,綜合5家券商已合共借出近521億元孖展額,相當於公開發售超 ...
本地傳媒引述消息指,昨日(5日)起招股的無收入生物科技上市公司沛嘉醫療(09996.HK)已錄得近521億元孖展,相當於其公開發售部份超購221倍,並錄得超過10張「 ...
Raffles暗盤急升36% 新加坡室內裝修服務供應商Raffles Interior(1376)今日掛牌,上市前夕暗盤造好。輝立交易平台顯示,Raffles開市報0.71元,較招股價0.5元 ...
兩只「重磅」股份昨同日展開招股,生物科技板塊的沛嘉醫療-B(9996)以及物管板塊的建業新生活(9983)同場「硬撼」。不過,沛嘉首日便...
料抽15萬股才穩中一手建業新生活僅超購20倍.
沛嘉醫療(新上市編號:09996)首日招股,券商首日已錄強勁孖展認購,當中輝立孖展達200億元、耀才孖展達150億元、信誠孖展達105億元,首日整體市場的孖展額 ...

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.